312 related articles for article (PubMed ID: 20920207)
1. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
Minami SS; Sidahmed E; Aid S; Shimoji M; Niikura T; Mocchetti I; Rebeck GW; Prendergast JS; Dealwis C; Wetzel R; Bosetti F; Matsuoka Y; Hoe HS; Turner RS
J Neuroinflammation; 2010 Sep; 7():57. PubMed ID: 20920207
[TBL] [Abstract][Full Text] [Related]
2. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
[TBL] [Abstract][Full Text] [Related]
3. Active full-length DNA Aβ
Rosenberg RN; Fu M; Lambracht-Washington D
Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
[TBL] [Abstract][Full Text] [Related]
4. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
Chauhan NB; Siegel GJ
Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
[TBL] [Abstract][Full Text] [Related]
6. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
[TBL] [Abstract][Full Text] [Related]
7. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
8. Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.
Wang CM; Devries S; Camboni M; Glass M; Martin PT
Neurobiol Dis; 2010 Sep; 39(3):409-22. PubMed ID: 20493257
[TBL] [Abstract][Full Text] [Related]
9. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
Zhang Y; Zou J; Yang J; Yao Z
Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
12. Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.
Camboni M; Wang CM; Miranda C; Yoon JH; Xu R; Zygmunt D; Kaspar BK; Martin PT
Neurobiol Dis; 2014 Feb; 62():31-43. PubMed ID: 24021662
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.
Frost JL; Liu B; Kleinschmidt M; Schilling S; Demuth HU; Lemere CA
Neurodegener Dis; 2012; 10(1-4):265-70. PubMed ID: 22343072
[TBL] [Abstract][Full Text] [Related]
14. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
16. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
18. Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice.
Zhang HY; Zhu K; Meng Y; Ding L; Wang JC; Yin WC; Yan Y; Cao YP
Brain Res Bull; 2018 Sep; 142():233-240. PubMed ID: 30077729
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.
Petrushina I; Davtyan H; Hovakimyan A; Davtyan A; Passos GF; Cribbs DH; Ghochikyan A; Agadjanyan MG
Mol Ther; 2017 Jan; 25(1):153-164. PubMed ID: 28129111
[TBL] [Abstract][Full Text] [Related]
20. Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model.
Morales-Corraliza J; Schmidt SD; Mazzella MJ; Berger JD; Wilson DA; Wesson DW; Jucker M; Levy E; Nixon RA; Mathews PM
Neurobiol Aging; 2013 Jan; 34(1):137-45. PubMed ID: 22608241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]